Novo Nordisk logo

Novo Nordisk

Novo Nordisk is a Danish pharmaceutical company focused on medicines for diabetes, obesity, and other serious chronic diseases.

ShareLink copied

The record

Vertical
Metabolic Health
Sub-segment
Diabetes and obesity medicines
Product type
Therapeutics
Stage
Public
Headquarters
Bagsvaerd, Denmark
Region
Europe
Founded
1923

What they do

Novo Nordisk traces its history to 1923 and is headquartered in Bagsvaerd, Denmark. Its largest products are diabetes and obesity treatments, including the semaglutide medicines Ozempic and Wegovy, along with a long line of insulins. Awiqli, its once weekly basal insulin for adults with type 2 diabetes, is one of the newer additions. The company also works in rare blood and endocrine disorders. Its medicines are prescribed by primary care physicians, endocrinologists, and obesity specialists, and reach patients through health systems, pharmacies, and payers in many countries.

Leadership & founders

Leadership as of 14 November 2026.

In The HealthTech Signal

Related companies

Is this your company? Get a Verified profile